CAS: 1380672-07-0 - G007-LK
Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-
CAS:1380672-07-0
Formula:
C25H16ClN7O3S
Purity:
%
Color and Shape:
Solid
Molecular weight:
529.9576
Ref: IN-DA0017XO
5mg | 67.00 € | ||
10mg | 110.00 € | ||
25mg | 151.00 € | ||
50mg | 217.00 € | ||
100mg | 488.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
G007-LK
CAS:1380672-07-0
G007-LK is a selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and …
Formula:
C25H16ClN7O3S
Purity:
98.17% - 98.62%
Color and Shape:
Solid
Molecular weight:
529.96
Ref: TM-T6842
1mg | 49.00 € | ||
2mg | 70.00 € | ||
5mg | 97.00 € | ||
10mg | 164.00 € | ||
25mg | 330.00 € | ||
50mg | 524.00 € | ||
100mg | 737.00 € | ||
1mL*10mM (DMSO) | 122.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
(E)-4-(5-(2-(4-(2-Chlorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4H-1,2,4-triazol-3-yl)vinyl)-1,3,4-oxadiazol-2-yl)benzonitrile
CAS:1380672-07-0
(E)-4-(5-(2-(4-(2-Chlorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4H-1,2,4-triazol-3-yl)vinyl)-1,3,4-oxadiazol-2-yl)benzonitrile is a drug candidate for the treatment of cancer. It has a pharmacokinetic profile …
Formula:
C25H16ClN7O3S
Purity:
Min. 95%
Molecular weight:
529.97 g/mol
Ref: 3D-FFC67207
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025